Inmune Bio Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: Oct 24, 2024 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | Oct 24, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, financials
TL;DR
Inmune Bio dropped an 8-K, likely with financial or operational updates. Watch closely.
AI Summary
On October 24, 2024, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and other significant corporate activities. Specific details regarding the nature of these events or financial statements are not elaborated in the provided text.
Why It Matters
This filing signals to investors and the market that Inmune Bio, Inc. has made significant disclosures or updates, potentially impacting its stock value and future business operations.
Risk Assessment
Risk Level: medium — 8-K filings can contain material information, but the provided text lacks specific details about the nature of the events, making it difficult to assess the immediate impact.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- October 24, 2024 (date) — Date of earliest event reported
FAQ
What specific "Other Events" are being reported by Inmune Bio, Inc. in this 8-K filing?
The provided text for the 8-K filing lists "Other Events" as an item information, but does not specify the nature of these events.
What is the significance of the "Financial Statements and Exhibits" being filed?
The filing of "Financial Statements and Exhibits" suggests that Inmune Bio, Inc. is providing updated financial information or related documentation to the SEC, which could include earnings reports or other financial disclosures.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on October 24, 2024.
What is Inmune Bio, Inc.'s principal executive office address?
Inmune Bio, Inc.'s principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
What is Inmune Bio, Inc.'s IRS Employer Identification Number?
Inmune Bio, Inc.'s IRS Employer Identification Number is 47-5205835.
Filing Stats: 463 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-10-24 16:00:22
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per shares INMB The NASDAQ Stock Ma
Filing Documents
- ea0218524-8k_inmune.htm (8-K) — 34KB
- ea021852402ex99-1_inmune.htm (EX-99.1) — 13KB
- ex99-1_001.jpg (GRAPHIC) — 2KB
- 0001213900-24-090366.txt ( ) — 225KB
- inmb-20241024.xsd (EX-101.SCH) — 3KB
- inmb-20241024_lab.xml (EX-101.LAB) — 33KB
- inmb-20241024_pre.xml (EX-101.PRE) — 22KB
- ea0218524-8k_inmune_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INMUNE BIO INC. Date: October 24, 2024 By: /s/ David Moss David Moss Chief Financial Officer 2